AbbVie is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.... Show more
Rating: Hold
Symbol: ABBV
Exchange: NYSE

AbbVie Financial Health

Profitability:5.39/10

AbbVie has worst Profitability than 50% of the companies on the Drug Manufacturers industry

Net Margin: 24.77%

AbbVie has better Net Margin than 75% of the companies on the Drug Manufacturers industry


ROE (Return on Equity): -26.05%

AbbVie has worst ROE (Return on Equity) than 88.89% of the companies on the Drug Manufacturers industry


ROA (Return on Assets): 2.84%

AbbVie has better ROA (Return on Assets) than 75% of the companies on the Drug Manufacturers industry


Operating Efficiency:9.31/10

AbbVie has worst Operating Efficiency than 50% of the companies on the Drug Manufacturers industry

Operating Margin: 37.08%

AbbVie has worst Operating Margin than 50% of the companies on the Drug Manufacturers industry


Liquidity:8.78/10

AbbVie has better Liquidity than 91.67% of the companies on the Drug Manufacturers industry

Quick Ratio: 3.03

AbbVie has better Quick Ratio than 91.67% of the companies on the Drug Manufacturers industry


Operating Cash Flow Ratio: 0.86

AbbVie has better Operating Cash Flow Ratio than 83.33% of the companies on the Drug Manufacturers industry


Solvency:7.97/10

AbbVie has better Solvency than 75% of the companies on the Drug Manufacturers industry

Debt to Equity Ratio: -9.04

AbbVie has better Debt to Equity Ratio than 91.67% of the companies on the Drug Manufacturers industry


Interest Coverage Ratio: 0.86

AbbVie has better Interest Coverage Ratio than 83.33% of the companies on the Drug Manufacturers industry


AbbVie revenue by product or service
AbbVie revenue quarter by quarter
AbbVie operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more